ALMS
+$100K
11,317 sh @ $9
ALMS
ALUMIS INC.
SEC CIK 1847367
$20.90
−22.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
37
Most recent
Advertisement
At a glance
Insiders at ALMS have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.
Largest recent trade: Akkaraju Srinivas, ALMS's Director, spent $10M of their own money on 588,235 shares at $17, growing their stake 46%.
Most active filer: Akkaraju Srinivas, with 11 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for ALMS, newest firstALMS
+$78.6K
15,535 sh @ $5
ALMS
+$0
680,486 sh
ALMS
+$0
680,486 sh
ALMS
+$0
680,486 sh
Advertisement
ALMS
Akkaraju Srinivas, ALMS's Director, spent $10M of their own money on 588,235 shares at $17, growing their stake 46%.
+$10M
588,235 sh @ $17
ALMS
Foresite Labs, Llc, ALMS's 10% owner, spent $2M of their own money on 117,647 shares at $17, growing their stake 2%.
+$2M
117,647 sh @ $17
ALMS
Foresite Labs, Llc, ALMS's 10% owner, spent $5M of their own money on 294,117 shares at $17, growing their stake 11%.
+$5M
294,117 sh @ $17
ALMS
Foresite Capital Management Vi Llc, ALMS's 10% owner, spent $2M of their own money on 117,647 shares at $17, growing their stake 2%.
+$2M
117,647 sh @ $17
ALMS
Foresite Capital Management Vi Llc, ALMS's 10% owner, spent $5M of their own money on 294,117 shares at $17, growing their stake 11%.
+$5M
294,117 sh @ $17
ALMS
Tananbaum James B., ALMS's 10% owner, spent $2M of their own money on 117,647 shares at $17, growing their stake 2%.
+$2M
117,647 sh @ $17
ALMS
Tananbaum James B., ALMS's 10% owner, spent $5M of their own money on 294,117 shares at $17, growing their stake 11%.
+$5M
294,117 sh @ $17
ALMS
Akkaraju Srinivas, ALMS's Director, spent $581.5K of their own money on 64,969 shares at $9, growing their stake 6%.
+$581.5K
64,969 sh @ $9
ALMS
Akkaraju Srinivas, ALMS's Director, spent $701K of their own money on 70,028 shares at $10, growing their stake 6%.
+$701K
70,028 sh @ $10
ALMS
Akkaraju Srinivas, ALMS's Director, spent $551.3K of their own money on 51,380 shares at $11, growing their stake 4%.
+$551.3K
51,380 sh @ $11
ALMS
Akkaraju Srinivas, ALMS's Director, spent $540.1K of their own money on 66,027 shares at $8, growing their stake 7%.
+$540.1K
66,027 sh @ $8
ALMS
Akkaraju Srinivas, ALMS's Director, spent $775K of their own money on 100,000 shares at $8, growing their stake 11%.
+$775K
100,000 sh @ $8
ALMS
Akkaraju Srinivas, ALMS's Director, spent $724.8K of their own money on 96,000 shares at $8, growing their stake 12%.
+$724.8K
96,000 sh @ $8
ALMS
Akkaraju Srinivas, ALMS's Director, spent $644.2K of their own money on 86,350 shares at $7, growing their stake 12%.
+$644.2K
86,350 sh @ $7
ALMS
Akkaraju Srinivas, ALMS's Director, spent $295.7K of their own money on 38,702 shares at $8, growing their stake 6%.
+$295.7K
38,702 sh @ $8
ALMS
Akkaraju Srinivas, ALMS's Director, spent $370.8K of their own money on 48,537 shares at $8, growing their stake 8%.
+$370.8K
48,537 sh @ $8
ALMS
Foresite Capital Management Vi Llc, ALMS's 10% owner, spent $532.9K of their own money on 72,212 shares at $7, growing their stake 3%.
+$532.9K
72,212 sh @ $7
ALMS
Tananbaum James B., ALMS's 10% owner, spent $532.9K of their own money on 72,212 shares at $7, growing their stake 3%.
+$532.9K
72,212 sh @ $7
ALMS
Foresite Labs, Llc, ALMS's 10% owner, spent $532.9K of their own money on 72,212 shares at $7, growing their stake 3%.
+$532.9K
72,212 sh @ $7
ALMS
Akkaraju Srinivas, ALMS's Director, spent $905.3K of their own money on 125,743 shares at $7, growing their stake 24%.
+$905.3K
125,743 sh @ $7
ALMS
Foresite Labs, Llc, ALMS's 10% owner, spent $1.25M of their own money on 190,500 shares at $7, growing their stake 8%.
+$1.25M
190,500 sh @ $7
ALMS
Foresite Capital Management Vi Llc, ALMS's 10% owner, spent $1.25M of their own money on 190,500 shares at $7, growing their stake 8%.
+$1.25M
190,500 sh @ $7
ALMS
Tananbaum James B., ALMS's 10% owner, spent $1.25M of their own money on 190,500 shares at $7, growing their stake 8%.
+$1.25M
190,500 sh @ $7
ALMS
Foresite Labs, Llc, ALMS's 10% owner, spent $726.5K of their own money on 117,374 shares at $6, growing their stake 5%.
+$726.5K
117,374 sh @ $6
ALMS
Foresite Capital Management Vi Llc, ALMS's 10% owner, spent $726.5K of their own money on 117,374 shares at $6, growing their stake 5%.
+$726.5K
117,374 sh @ $6
Advertisement
About ALMS insider activity
This page tracks every recent Form 4 filed for ALUMIS INC. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is ALMS insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for ALUMIS INC. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.